Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. It also owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases.